DRONTAL ALLWORMER - DOGS

Main information

  • Trade name:
  • DRONTAL ALLWORMER FOR DOGS
  • Pharmaceutical form:
  • ORAL TABLET
  • Units in package:
  • 100Tab
  • Class:
  • Veterinary Medicine
  • Medicine domain:
  • Animals
  • Medicine type:
  • Allopathic drug
  • Manufactured by:
  • BAYER AUSTRALIA

Documents

Localization

  • Available in:
  • DRONTAL ALLWORMER FOR DOGS
    Australia
  • Language:
  • English

Therapeutic information

  • Therapeutic group:
  • DOG | DOG - LACTATING | DOG - PREGNANT | BITCH | CASTRATE | LACTATING DOG | PREGNANT DOG | PUPPY
  • Therapeutic area:
  • anthelmintic
  • Therapeutic indications:
  • GIARDIA SPP. | HOOKWORM - ANCYLOSTOMA CEYLANICUM | HOOKWORM - BUNOSTOMUM SPP. | ROUNDWORM | TAPEWORM | WHIPWORM - TRICHURIS VULPIS | TOXOCARA MYSTAX | TOXOCARA SPP.
  • Product summary:
  • For the control of all gastrointestinal worms including: roundworm, hookworm, whipworm and tapeworm in dogs, puppies and pregnant and lactating bitches, and to control shedding of oocysts of the protozoan Giardia sp in dogs.DOES NOT CONTROL HEARTWORM. TO BE USED BY, OR UNDER THE DIRECTION OF, A REGISTERED VETERINARY SURGEON ONLY.

Other information

Status

  • Source:
  • Australian Pesticides and Veterinary Medicines Authority (APVMA)
  • Authorization status:
  • Registered and available
  • Authorization number:
  • 35822/0210
  • Authorization date:
  • 26-03-2010
  • Last update:
  • 15-06-2017

Patient Information leaflet: composition, indications, side effects, dosage, interactions, adverse reactions, pregnancy, lactation

Drontal

Allwormer

FOR DOGS

FOR ANIMAL TREATMENT ONLY

®

®

1 0 0 T A B L E T S

1 0 0 T A B L E T S

Drontal

Allwormer

FOR DOGS

®

®

Drontal

Allwormer

FOR DOGS

®

®

Drontal

Allwormer

FOR DOGS

®

®

Drontal

Allwormer

FOR DOGS

®

®

For the control of all

gastrointestinal worms:

roundworm, hookworm,

whipworm and tapeworm

in dogs, puppies, pregnant

and lactating bitches,

and to control the shedding of

oocysts of the protozoan

Giardia sp. in dogs.

For the control of all

gastrointestinal worms:

roundworm, hookworm,

whipworm and tapeworm

in dogs, puppies, pregnant

and lactating bitches,

and to control the shedding of

oocysts of the protozoan

Giardia sp. in dogs.

Each tablet contains

50 mg PRAZIQUANTEL

49.8 mg PYRANTEL as PYRANTEL EMBONATE

250 mg FEBANTEL

TO BE USED BY, OR UNDER THE DIRECTION OF, A REGISTERED VETERINARY SURGEON ONLY.

DRONTAL is recommended for the control of all gastrointestinal worms in dogs including:

Roundworm

Toxocara canis, Toxascaris leonina.

Hookworm

Ancylostoma caninum, Ancylostoma braziliense (This hookworm is usually restricted to tropical areas

in Australia), Ancylostoma ceylanicum, Uncinaria stenocephala.

Whipworm

Trichuris vulpis.

Tapeworm

Echinococcus granulosus (hydatid tapeworm), Dipylidium caninum (common fl ea tapeworm),

Taenia spp., Taenia ovis, T. pisiformis, T. hydatigena.

and to control the shedding of oocysts of the protozoan Giardia sp. in dogs.

Does not control heartworm (Dirofi laria immitis).

READ THE ENCLOSED LEAFLET BEFORE USING THIS PRODUCT.

DIRECTIONS FOR USE

Dosage: 1 tablet per 10kg bodyweight. (Administer this dose once for worms, and for 3 consecutive days for Giardia).

If worm problems persist, consult a veterinarian.

Disposal: Dispose of empty container and packaging by wrapping in paper and putting in garbage.

Warranty: Bayer Australia Limited (BAL) warrants that this product is of merchantable quality and fi t for it’s intended

purpose indicated on this label. Notwithstanding anything else contained on this label, BAL’s liability is limited to

replacing this product or supplying equivalent product or paying the cost of replacing this product, at its discretion.

STORE BELOW 30°C (Room Temperature)

APVMA Approval No 35822/0609

For batch number and expiry date see carton lid.

BAYER AUSTRALIA LTD.

ACN 000 138 714

875 Pacifi c Highway PYMBLE NSW 2073

DRONTAL

, and DRONTAL ALLWORMER

are registered trademarks of

Bayer AG, Leverkusen, Germany.

DRONTAL

, and DRONTAL ALLWORMER

Manufactured in Germany.

1006362 06/09

BLACK PMS1655

35822_44556_100__Primary carton_MPL_V01

Date: 0609

Dimensions: 23cm x 14.5 cm

Scale: Approximately 56% when printed to A4

APPROVED

LABEL

Info

pest

Verified

FOR ANIMAL TREATMENT ONLY

Drontal

®

Allwormer

®

FOR DOGS

Each tablet contains

50 mg PRAZIQUANTEL

250 mg FEBANTEL

1 0 0 TA B L E T S

STORE BELOW 30ºC (Room Temperature).

Batch

Expiry

APVMA Approval No 35822/0609

BAYER AUSTRALIA LTD.

ACN 000 138 714

875 Pacific Highway Pymble NSW 2073

DRONTAL and DRONTAL ALLWORMER are registered

trademarks of Bayer AG, Leverkusen, Germany.

MN1007253 07/03

DRONTAL is recommended for the control of all gastrointestinal worms in

dogs including: Roundworm Toxocara canis, Toxascaris leonina. Hookworm

Ancylostoma caninum, Ancylostoma braziliense (This hookworm is usually

restricted to tropical areas in Australia), Ancylostoma ceylanicum, Uncinaria

stenocephala.

Whipworm

Trichuris

vulpis.

Tapeworm

Echinococcus

granulosus

(hydatid

tapeworm),

Dipylidium

caninum

(common

flea

tapeworm), Taenia spp. and to control the shedding of oocysts of the protozoan

Giardia sp. in dogs. Does not control heartworm (Dirofilaria immitis).

READ THE ENCLOSED LEAFLET BEFORE USING THIS PRODUCT.

DIRECTIONS FOR USE:

Dosage: 1 tablet per 10kg bodyweight. (Administer this dose once for worms, and for

3 consecutive days for Giardia)

Disposal: Dispose of empty container by wrapping with paper and putting in garbage.

Warranty:

Bayer Australia Limited (BAL) warrants that this product is of merchantable

quality and fit for it’s intended purpose indicated on this label. Notwithstanding anything

else contained on this label, BAL’s liability is limited to replacing this product or supplying

equivalent product or paying the cost of replacing this product, at its discretion.

TO BE USED BY, OR UNDER THE DIRECTION OF,

A REGISTERED VETERINARY SURGEON ONLY

49.8 mg PYRANTEL as PYRANTEL EMBONATE

Ph: (02) 4351 1350 Fax: (02) 4351 1320

ARTWORK / PROOF APPROVAL

T H I S S I G N E D P R O O F M U S T B E R E T U R N E D T O PA C I F I C L A B E L S P R I O R T O P R I N T I N G

IS TRIM SIZE CORRECT

IS TEXT / COPY CORRECT

ARE COLOURS CORRECT

IS APN SIZE AND No. CORRECT

All care has been taken to produce this artwork but FINAL RESPONSIBILITY IS LEFT WITH YOU, our valued client. PLEASE CHECK CAREFULLY and sign this notice. Should

any alterations be required mark clearly and return promptly. PLEASE NOTE: AUTHORS CORRECTIONS AT CLIENTS EXPENSE. COST TO BE ADVISED FOR APPROVAL.

MAGENTA

CYAN

BLACK

O.K. to print:

Changes & Re-submit:

Date:

MAGENTA

BLACK

PANTONE 021

BLACK

F/O No

DATE

ART VERSION

28/7/09

17418

95 mm

PLEASE NOTE: ART COSTS INCLUDE 1ST AUTHORS CORRECTIONS.

SUBSEQUENT CHANGES WILL BE CHARGED AT OUR MINIMUM RATE.

48 mm

35822_44556_100_Immediate bottlelabel_MPL_V01

Date: 0609

Dimensions: 95 mm x 48 mm

Scale: Approximately 100% when printed to A4

APPROVED

LABEL

It should be noted that the hydatid tapeworm poses a severe risk to

human health by transmission to humans from infected dogs.

HOOKWORMS & ROUNDWORMS

Dogs and Puppies: treat at 2, 4, 8 and 12 weeks and then every

month until six months of age; thereafter every 3 months or on

veterinary advice.

Pregnant Bitches: treat prior to mating, then 10 days before whelping

and at 2 and 4 weeks after whelping.

WHIPWORMS

Treat every 6 to 8 weeks after 3 months of age.

TAPEWORMS

Treat every 3 months except in a hydatid tapeworm area where every

6 weeks is recommended, or on veterinary advice. Dogs can become

reinfested with worms and treatment should be repeated. Read the

retreatment recommendations below or consult your veterinarian.

Dipylidium caninum tapeworms are transmitted by fleas. Control of this

tapeworm should include flea control measures in addition.

Worms, if present, may not appear in the droppings at all, or may not

appear for up to 48 hours after treatment.

GIARDIA

This protozoan parasite is found commonly in dogs and may be the

cause of diarrhoea, particularly in pups. It is more common amongst

dogs living in multi-dog households and kennels. Giardia also occurs

in humans and has historically been considered a potential zoonosis,

however

recent

studies

suggest

that

host-specific

species

exist. Control of Giardia is difficult because the oocysts are resistant

and long-lived in the environment. Diagnosis of suspected Giardia

infection should be confirmed by a veterinary surgeon. Some evidence

indicates that bathing and a move to a non-contaminated environment

in conjunction with treatment will improve overall control.

Compatibility

DRONTAL may be combined with other treatments, for example

heartworm prevention, flea or tick treatment.

Safety

DRONTAL may be given safely to all dogs including old animals,

young pups, working dogs and greyhounds. It may be given to

pregnant bitches but is only clinically indicated in the last 10 days

prior to whelping. Side Effects: Vomiting may be observed in a

small number of dogs after administration.

Note

Zipper worm (Spirometra erinacei) is a less common tapeworm.

If segments are seen in the droppings less than 2 weeks after

treatment they probably belong to this worm. When tapeworm

treatment

only

required,

this

case,

give

DRONCIT

Tapewormer for Dogs and Cats which is specifically for tapeworm

treatment.

Disposal

Dispose of empty container by wrapping with paper and putting in

the garbage.

RETREATMENT RECOMMENDATIONS

Worms often reinfest dogs so it is necessary to:

treat the dog itself,

(ii)

reduce environmental contamination by daily disposal

of droppings,

(iii)

remove tapeworm intermediate hosts eg. fleas.

continued...

Drontal  Allwormer 

FOR SMALL DOGS AND PUPPIES

Drontal  Allwormer 

FOR DOGS

Drontal  Allwormer 

FOR LARGE DOGS

FOR ANIMAL TREATMENT ONLY

®

®

®

®

®

®

Product

Praziquantel

Pyrantel

Febantel

(as Pyrantel embonate)

Drontal Allwormer for

15 mg

14.9

75 mg

Small Dogs and Puppies

Drontal Allwormer

50 mg

49.8 mg

250 mg

for Dogs

Drontal Allwormer for

175 mg

174.4 mg

875 mg

Large Dogs

Each tablet contains

TO bE USED bY, OR UNDER THE DIRECTION OF,

A REGISTERED VETERINARY SURGEON ONLY

DRONTAL

is recommended for the control of all gastrointestinal worms

in dogs including:

Roundworm

Toxocara canis, Toxascaris leonina.

Hookworm

Ancylostoma caninum, Ancylostoma braziliense

(This hookworm is usually restricted to tropical areas

in Australia), Ancylostoma ceylanicum, Uncinaria

stenocephala.

Whipworm

Trichuris vulpis.

Tapeworm

Echinococcus granulosus (hydatid tapeworm), Dipylidium

caninum (common flea tapeworm), Taenia spp., Taenia

ovis, T. pisiformis, T. hydatigena.

and to control the shedding of oocysts of the protozoan Giardia sp. in

dogs.

Does not control heartworm (Dirofilaria immitis)

DIRECTIONS FOR USE

DRONTAL is given as a single dose by mouth. Fasting prior to dosing

is NOT necessary. IT IS ESSENTIAL TO WEIGH DOGS BEFORE

TREATMENT. See Dosing Recommendations below.

If worm problems persist consult a veterinarian.

Dosage

Small dogs and puppies

(using Drontal Allwormer for Small Dogs and Puppies)

bodyweight

Tablets

500g - 1.5kg

1.6 - 3kg

3.1 - 6kg

6.1 - 9kg

Medium dogs (using Drontal Allwormer for Dogs)

Large dogs (using Drontal Allwormer for Large Dogs)

Worms - Administer the above dosage once.

Giardia - Administer the above dosage for three

consecutive days. DRONTAL should be used only in

proven cases of Giardia sp. infection.

HYDATID TAPEWORM

A single dose of DRONTAL is all that is required. However, this dose

should be repeated every 6 weeks to ensure that newly acquired

hydatid

tapeworms

expelled

before

reaching

maturity.

Dogs

should not be fed, or allowed to feed on, offal from any species.

Dogs in hydatid areas should be treated every 6 weeks. It is

important to ensure that the dog does not acquire offal in order to

break the life cycle of the hydatid tapeworm.

bodyweight

Tablets

20 - 35 kg

35.1 - 52 kg

52.1 - 70 kg

70.1 - 87 kg

Over 87 kg

bodyweight

Tablets

1.5 - 2.5 kg

2.6 - 5 kg

5.1 - 10 kg

Over 10 kg

1 tablet for every 10kg

bodyweight.

Round off doses to the

nearest 1/2 tablet above.

Treat at

2,4,8,12 weeks;

then 4,5,6

months of age.

Every 3 months.

Every 6 weeks in Hydatid

infested locations.

If whipworm is a problem

retreat every 6-8 weeks.

Prior to mating, 10-days

before whelping and

2 and 4 weeks after

whelping.

Follow the retreatment recommendations in the table below:

PUPPIES

ADULTS

PREGNANT/LACTATING

(over 6 months)

bITCHES

These

recommendations

general

nature.

specific

instances where infestation is particularly heavy or many dogs

are housed together, a veterinary surgeon should be consulted.

Flea tapeworms can reinfest dogs and begin producing segments

2-3 weeks after a treatment. If segments reappear before the next

DRONTAL treatment is due, either re-treat with DRONTAL or use

DRONCIT as an intermediate, tapeworm only, treatment.

Retreatment for Giardia depends on the circumstances and should

be guided by your veterinary surgeon. A single 3 day treatment may

be sufficient in single dog situations, but repeat treatments may be

necessary in kennels and shelters.

Storage: Store below 30°(Room Temperature)

Presentation and APVMA Approval Nos

Drontal Allwormer for Small Dogs & Puppies

50 tablets

35825/0210

Drontal Allwormer for Dogs

100 tablets

35822/0210

Drontal Allwormer for Large Dogs

70 tablets

35824/0210

Warranty: Bayer Australia Limited (BAL) warrants that this product is

of merchantable quality and fit for it's intended purpose indicated on

this label. Notwithstanding anything else contained on this label, BAL's

liability is limited to replacing this product or supplying equivalent product

or paying the cost of replacing this product, at its discretion.

bAYER AUSTRALIA LTD.

ACN 000 138 714

875 Pacific Highway, Pymble NSW 2073

DRONTAL

, DRONTAL ALLWORMER

and DRONCIT

are registered

trademarks of Bayer AG, Leverkusen, Germany.

02/10

1007733

42773 Bayer Drontal Dog.indd 1-3

11/02/10 2:17 PM

35825,35824,35822_45912,49131,49120_50,100,70_Common leaflet_MPL_V01

Date: 0210

Dimensions: 207mm x 100mm

Scale: Approx. 100% when printed to A4

Info

pest

Verified

13-11-2018

Oscor Inc. Issues Recall Product Expansion of TB – Temporary Bipolar Pacing Lead (Unshrouded 2 mm Pins Models)

Oscor Inc. Issues Recall Product Expansion of TB – Temporary Bipolar Pacing Lead (Unshrouded 2 mm Pins Models)

On September 26, 2018 Oscor notified customers of a recall for certain lots (Recall No. 1035166- 09/07/2018-01-R) of TB Unshrouded Bipolar Pacing Leads. As part of the recall correction activities, Oscor is retrieving any remaining inventory out in the field. The recall scope is being expanded to include expired inventory for devices distributed between December 21, 2011 to May 17, 2018. The recall expansion is to ensure proper disposition of expired units. The FDA has been notified and is aware Oscor In...

FDA - U.S. Food and Drug Administration

9-11-2018

Safety assessment of the substance Ln 1,4‐benzene dicarboxylic acid (with Ln = La, Eu, Gd, Tb) for use in food contact materials

Safety assessment of the substance Ln 1,4‐benzene dicarboxylic acid (with Ln = La, Eu, Gd, Tb) for use in food contact materials

Published on: Wed, 07 Nov 2018 00:00:00 +0100 The EFSA Panel on Food Contact Materials, Enzymes and Processing Aids (CEP Panel) assessed the safety of the additive Ln 1,4‐benzene dicarboxylic acid (with Ln = La, Eu, Gd, Tb) for use in food contact materials. It is a family of mixtures combining the four lanthanides lanthanum (La), europium (Eu), gadolinium (Gd) and/or terbium (Tb) in different proportions as their 1,4‐benzene dicarboxylate complexes, used as a taggant in plastics for authentication and ...

Europe - EFSA - European Food Safety Authority Publications

27-9-2018

Oscor Inc. Issues Recall of TB – Temporary Bipolar Pacing Lead (Unshrouded 2 mm Pins Models)

Oscor Inc. Issues Recall of TB – Temporary Bipolar Pacing Lead (Unshrouded 2 mm Pins Models)

During the use of some TB - Temporary Bipolar Pacing Leads, featuring the 2mm unshrouded connectors, the connector cap housing (see Picture 1, No. 2 Pin Cap and Cover) may slide and potentially expose the connection wire. In some instances, this may cause the wire to be more susceptible to loss of connectivity or breakage during movement of the cables causing interruption of the pacing system. The analysis of the returned devices attributed the failure to a design change of the cap housing of the pins. ...

FDA - U.S. Food and Drug Administration

29-8-2018

Risk to human and animal health related to the presence of 4,15‐diacetoxyscirpenol in food and feed

Risk to human and animal health related to the presence of 4,15‐diacetoxyscirpenol in food and feed

Published on: Thu, 16 Aug 2018 00:00:00 +0200 4,15‐Diacetoxyscirpenol (DAS) is a mycotoxin primarily produced by Fusarium fungi and occurring predominantly in cereal grains. As requested by the European Commission, the EFSA Panel on Contaminants in the Food Chain (CONTAM) assessed the risk of DAS to human and animal health related to its presence in food and feed. Very limited information was available on toxicity and on toxicokinetics in experimental and farm animals. Due to the limitations in the avai...

Europe - EFSA - European Food Safety Authority Publications

23-11-2018

.@US_FDA issues Class I Medical Device Recall, the most serious type of   recall: Oscor Recalls TB Temporary Bipolar Pacing Leads Due to  Connector Separation Causing Potential for Loss of Pacing. Find out  more:  https://go.usa.gov/xPHxF  #FDA #MedicalDe

.@US_FDA issues Class I Medical Device Recall, the most serious type of recall: Oscor Recalls TB Temporary Bipolar Pacing Leads Due to Connector Separation Causing Potential for Loss of Pacing. Find out more: https://go.usa.gov/xPHxF  #FDA #MedicalDe

. @US_FDA issues Class I Medical Device Recall, the most serious type of recall: Oscor Recalls TB Temporary Bipolar Pacing Leads Due to Connector Separation Causing Potential for Loss of Pacing. Find out more: https://go.usa.gov/xPHxF  #FDA #MedicalDevice pic.twitter.com/negJ6HU4x2

FDA - U.S. Food and Drug Administration